Labcorp to Buy Opko Health Unit Assets for Up to $872 Million
Labcorp said it will pay $722 million in cash, with up to $150 million more tied to revenue from a prostate cancer test.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Labcorp to buy select assets from Opko Health unit for up to $872 million
Oct 15 (Reuters) — Laboratory operator Labcorp said on Thursday it will buy some assets from Opko Health's subsidiary in a $722 million cash deal, with a potential additional payment of up to $150 million tied to revenue from a prostate cancer test. Shares of Opko Health were up 20% in premarket trading. Here are some